AL Amyloidosis: Treatment Approaches

Impact of the addition of daratumumab to the frontline treatment of patients with AL amyloidosisПодробнее

Treatment Options for AL Amyloidosis: Venetoclax and Teclistimab - Blood Cancer Video Library 2023Подробнее

Updates on AL Amyloidosis Treatment: What’s New in 2024Подробнее

Current approaches for managing R/R AL amyloidosisПодробнее

ARC TALKS Webinar: Clinical Trial Updates for the AL CommunityПодробнее

Expert Insights Into Amyloidosis: Musculoskeletal Pathology as an Early Warning Sign of AmyloidosisПодробнее

Expert Insights Into Amyloidosis: What is the Relationship Between AL Amyloidosis & Multiple MyelomaПодробнее

Expert Insights Into Amyloidosis: Raising Awareness of Cardiac AmyloidosisПодробнее

Treatment approaches for AL amyloidosis versus ATTR amyloidosisПодробнее

Treatment options available for patients with AL amyloidosis beyond chemotherapy & transplantПодробнее

AL amyloidosis: current and prospective treatmentsПодробнее

Is birtamimab an option for patients with advanced AL amyloidosis at high risk for early death?Подробнее

Novel treatment approaches being explored in amyloidosis: immunotherapeutic agents & venetoclaxПодробнее

Novel Non-transplant Approaches for the Treatment of AL AmyloidosisПодробнее

The importance of a multidisciplinary approach to treat amyloidosisПодробнее

Systemic AL Amyloidosis: Current Approach and Future Direction | OncotargetПодробнее

Current approaches to GvHD prophylaxis and treatmentПодробнее

Diagnosis and Treatment of AL AmyloidosisПодробнее

Treatment approaches for patients with TP53m AML ineligible for high intensity chemotherapyПодробнее

ARC Talks Webinar: Approaches to Treating Relapsed and Refractory AL AmyloidosisПодробнее